Nuveen’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $22.7M | Buy |
|
|||||
|
2025
Q2 | $15.1M | Sell |
|
|||||
|
2025
Q1 | $15.9M | Buy |
|
|||||
|
2024
Q4 | $27M | Buy |
|
|||||
|
2024
Q3 | $26.3M | Buy |
|
|||||
|
2024
Q2 | $20.7M | Sell |
|
|||||
|
2024
Q1 | $25.9M | Sell |
|
|||||
|
2023
Q4 | $24.2M | Buy |
|
|||||
|
2023
Q3 | $12.2M | Buy |
|
|||||
|
2023
Q2 | $6.18M | Buy |
|
|||||
|
2023
Q1 | $2M | Sell |
|
|||||
|
2022
Q4 | $2.52M | Sell |
|
|||||
|
2022
Q3 | $5.83M | Sell |
|
|||||
|
2022
Q2 | $7.5M | Buy |
|
|||||
|
2022
Q1 | $5.65M | Buy |
|
|||||
|
2021
Q4 | $7.16M | Buy |
|
|||||
|
2021
Q3 | $2.76M | Sell |
|
|||||
|
2021
Q2 | $2.8M | Buy |
|
|||||
|
2021
Q1 | $1.98M | Sell |
|
|||||
|
2020
Q4 | $1.94M | Sell |
|
|||||
|
2020
Q3 | $2.81M | Buy |
|
|||||
|
2020
Q2 | $2.74M | Buy |
|
|||||
|
2020
Q1 | $413K | Sell |
|
|||||
|
2019
Q4 | $709K | Sell |
|
|||||
|
2019
Q3 | $429K | Sell |
|
|||||
|
2019
Q2 | $742K | Buy |
|